Stock of the Day for October 7, 2024

Medtronic Stock Report

Medtronic
MDT 90-day performance NYSE:MDT Medtronic
Current Price
$92.04
-0.87 (-0.94%)
(As of 03:59 PM ET)
30 Day Performance
3.12%
  
 
90 Day Performance
6.51%
  
 
1 Year Performance
12.61%
  
 
Market Capitalization
$117.98B
P/E Ratio
25.42
Dividend Yield
3.09%
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

MDT Company Calendar

MAY. 21, 2025
Last Earnings
JUN. 27, 2025
Ex-Dividend for 7/11 Dividend
JUL. 11, 2025
Dividend Payable
AUG. 14, 2025
Today
AUG. 19, 2025
Next Earnings (Estimated)
APR. 30, 2026
Fiscal Year End

Recent Medtronic News

Medtronic put volume heavy and directionally bearish
Medtronic announces cash dividend for second quarter of fiscal year 2026
Boston Partners Acquires 3,809,450 Shares of Medtronic PLC (NYSE:MDT)
Triglav Skladi D.O.O. Purchases 41,500 Shares of Medtronic PLC (NYSE:MDT)
3 Things You Need to Know if You Buy Medtronic Today
Gulf International Bank UK Ltd Reduces Holdings in Medtronic PLC (NYSE:MDT)
Medtronic PLC (NYSE:MDT) Position Lifted by National Pension Service
LGT Group Foundation Decreases Stake in Medtronic PLC (NYSE:MDT)
This report was written on August 14, 2025. This report first appeared on MarketBeat.com.